Vetosine is a startup based in Switzerland.
Vetosine is developing and commercializing a disease modifying osteoarthritis drug (DMOAD) for animals, initially focusing on dogs, to improve therapy options beyond NSAIDs, diet, and exercise by maintaining healthy joint cartilage.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.